CardioMEMS: Unveiling the Company's Financial Strength and Market Value
Financial Strength and Funding CardioMEMS has established a strong financial footing. With over $209 million raised in funding and annual revenue of $10.6 million, it is a prominent player in the cardiac monitoring market. Its 14 investors, including St. Jude Medical and Vision Capital Advisors, provide stable support. In 2014, St. Jude Medical acquired CardioMEMS for $375 million, recognizing the value of its innovative technology. This transaction solidified CardioMEMS’s position and enhanced St....